IMC Chicago
XERS icon

IMC Chicago’s Xeris Biopharma Holdings XERS Stock Holding History

IMC Chicago’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$198K Buy
34,200
+7,300
+27% +$48.4K ﹤0.01% 5022
2025
Q4 		$211K Buy
+26,900
New +$212K ﹤0.01% 3991

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IMC Chicago's XERS Position: Q1 2026 in Review

IMC Chicago opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 10,881 shares worth $63.1K. The stake represents ﹤0.01% of the portfolio and ranks #5474 among its holdings.

237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • IMC Chicago held 10,881 shares of Xeris Biopharma Holdings worth $63.1K as of Q1 2026.
  • Xeris Biopharma Holdings was a new IMC Chicago position in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5474 holding.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.